TMEM97 knockdown inhibits 5?fluorouracil resistance by regulating epithelial?mesenchymal transition and ABC transporter expression via inactivating the Akt/mTOR pathway in 5?fluorouracil?resistant colorectal cancer cells
Chemical Biology and Drug Design
FEBRUARY 22, 2024
TMEM97 knockdown re-sensitized HCT116/R and SW480/R cells to 5-FU by inhibiting EMT and ABC transporter expression through inactivation of Akt/mTOR pathway. These results indicate that TMEM97 may be a promising therapeutic target to combat 5-FU resistance in CRC. Abstract Resistance to 5-fluorouracil (5-FU) is still a primary setback to the success of colorectal cancer (CRC) chemotherapy.
Let's personalize your content